ConclusionsĮRAS significantly decreases the TTS, LOS, and complication rate without increasing readmission rate and mortality, which adds to the evidence that the implementation of ERAS is beneficial to patients undergoing hip fracture repair surgeries.Īs one of the most common injuries in the elderly, hip fracture is predicted to reach 7.3–21.3 million cases around the world by 2050 (Leigheb et al. Moreover, no significant change was found in the 30-day readmission rate or 30-day and 1-year mortality. The meta-analysis showed that the TTS, LOS, and overall complication rate were significantly reduced in the ERAS group compared with the control group ( p < 0.01).
ResultsĪ total of 7 published studies (9869 patients) were finally included, and these were all cohort studies. The data analysis was carried out by Review Manager 5.3. The secondary outcomes included the 30-day readmission rate, overall complication rate, specific complication rate (delirium and urinary tract infection), and 30-day and 1-year mortality. All of the included studies met the inclusion criteria. Published literature was searched in the PubMed, EMBASE, and Cochrane Library databases. The objective of this review was to investigate the clinical prognosis of ERAS programs in terms of (1) hospital-related endpoints (time to surgery, length of stay ), (2) readmission rate, (3) complications, and (4) mortality. However, uncertainty still remains regarding the effect of ERAS on hip fractures. Enhanced recovery after surgery (ERAS) programs have achieved promising results in many surgical specialties.
0 kommentar(er)
